Hound Partners’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-50,000
Closed -$2.42M 28
2019
Q2
$2.42M Buy
+50,000
New +$2.21M 0.12% 25

Other funds holding ADPT

Hound Partners's ADPT Position: Q3 2019 in Review

Hound Partners sold out of Adaptive Biotechnologies (ADPT) in Q3 2019, closing a stake of 50,000 shares — an estimated $2.42M sold.

Hound Partners first reported a position in ADPT in Q2 2019 and held it in 1 quarter. The position peaked at $2.42M in Q2 2019. 117 funds tracked by Wall St. Rank hold ADPT as of Q3 2019.

  • Hound Partners reported no remaining Adaptive Biotechnologies position as of Q3 2019 after selling out during the quarter.
  • Hound Partners sold 50,000 Adaptive Biotechnologies shares in Q3 2019, an estimated $2.42M.
  • Hound Partners first reported a position in Adaptive Biotechnologies in Q2 2019 and held it in 1 quarter.
  • Hound Partners's Adaptive Biotechnologies position peaked at $2.42M in Q2 2019.
  • 117 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2019.

Based on Hound Partners's 13F filing for Q3 2019, filed 14 Nov 2019.